Pharmacovigilance
Table of Contents
Introduction
Pharmacovigilance (PV) is the science and practice of detecting, assessing, understanding, and preventing adverse effects or other drug-related problems. It plays a critical role in ensuring drug safety throughout the product lifecycle, from clinical trials to post-market surveillance.
Definitions and Concepts
- Adverse Drug Reaction (ADR): A harmful and unintended response to a medicinal product.
- Signal Detection: The process of identifying potential safety concerns from pharmacovigilance data.
- Risk Management Plan (RMP): A documented strategy to identify, monitor, and mitigate risks associated with a medicinal product.
- Periodic Safety Update Report (PSUR): A regulatory document summarizing risk-benefit evaluations of a drug at regular intervals.
Importance
Pharmacovigilance is essential to public health as it ensures drug safety, minimizes risks, and improves patient outcomes. It facilitates regulatory compliance for pharmaceutical companies and helps maintain trust in healthcare systems.
- Enhances patient safety by identifying and mitigating adverse drug effects.
- Supports regulatory decision-making through post-marketing surveillance.
- Contributes to continuous product improvement and labeling updates.
- Improves healthcare professionals’ knowledge about drug interactions and contraindications.
Principles or Methods
- Spontaneous Reporting: Collection of ADR reports from healthcare professionals and patients.
- Electronic Health Records (EHR) Mining: Use of AI/Big Data to identify patterns of drug-related harm.
- Case-Control Studies: Epidemiological approaches to establish associations between drugs and adverse events.
- Regulatory Frameworks: Compliance with guidelines from agencies like the FDA, EMA, and WHO.
Application
Pharmacovigilance is integrated into various stages of drug development and regulatory processes, ensuring continuous monitoring and safety evaluations.
- Clinical Trials: Detection of early safety concerns within controlled settings.
- Post-Marketing Surveillance: Monitoring the real-world use of drugs for previously undetected ADRs.
- Regulatory Submissions: Compliance with reporting requirements for global health authorities.
- Artificial Intelligence Integration: Automating pharmacovigilance workflows for improved efficiency.